H40.1
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Medical indication for IOP lowering surgery; type of surgery according to the surgeon's preference and the patient's criteria and risk factors • Willingness of patient to cooperate with study design • Written informed consent
Exclusion criteria
Exclusion criteria: • Withdrawal from planned surgical intervention • Patients lacking capability to consent or under age • Patients with known addictions • Language barrier
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| •Strict success: IOP = 18 mmHg, = 6 mmHg and 20% IOP decrease without antiglaucomatous medication •Complete success: IOP = 18mmHg and = 6 mmHg without antiglaucomatous medication •Qualified success: IOP = 18mmHg and = 6 mmHg with antiglaucomatous medication | — |
Secondary
| Measure | Time frame |
|---|---|
| • Evaluation of risk factors leading to failure • Difference of number of antiglaucomatous medications • Evaluation of function (best corrected visual acuity, visual field examination: mean deviation/defect) • Evaluation of anatomy (OCT: peripapillary retinal nerve fiber thickness, macular ganglion cell thickness, refractive error, endothelial cell count in case of implant surgeries) | — |
Countries
Germany
Contacts
Augeklinik und Poliklinik, Universitätsmedizin der Johannes Gutenberg-Universität Mainz